Log in or Sign up for Free to view tailored content for your specialty!
Neuro-Oncology News
National initiative establishes research priorities for VTE in cancer
An estimated 900,000 cases of venous thromboembolism are diagnosed each year in the United States, according to CDC statistics.
Breaching the blood–brain barrier: Researchers intensify quest for ‘holy grail of neuro-oncology’
The rapid development of gene sequencing and targeted cancer treatments has allowed oncologists to deliver highly effective personalized therapies with near-pinpoint accuracy, killing tumor cells and sparing healthy ones.
Log in or Sign up for Free to view tailored content for your specialty!
Studies highlight effects of insurance disparities on cancer treatment, outcomes
Uninsured patients and patients with Medicaid who have germ cell tumors or glioblastoma multiforme experienced poorer outcomes than their privately insured counterparts, according to results of two studies published in Cancer.
Postoperative radiotherapy deferral on the rise in pediatric medulloblastoma
The deferral of postoperative radiotherapy in pediatric patients with medulloblastoma has increased in recent years, according to the results of a national database survey.
The University of Texas MD Anderson Cancer Center named best cancer hospital in nation
The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country.
Long-term exposure to particulate matter increases cancer mortality
Long-term exposure to ambient fine particulate matter significantly increased risk for cancer mortality among elderly people in Hong Kong, according to study results.
Opinions on prognosis often discordant between patients and their oncologists
Patients with advanced cancers frequently interpreted their prognoses differently from their oncologists, according to the results of a cross-sectional study published in JAMA Oncology.
Multiple mental health symptoms common in adolescent cancer survivors
Adolescent survivors of childhood cancers frequently experienced concurrent behavioral, emotional and social deficits, according to research published in Journal of Clinical Oncology.
Radiosurgery alone lessens cognitive decline for patients with limited brain metastases
The use of stereotactic radiosurgery without adjuvant whole-brain radiation lessened cognitive deterioration at 3 months among patients with one to three brain metastases, according to the results of multicenter, randomized trial.
Second malignancies, death common among cancer survivors
Approximately one in 12 patients with a common primary tumor were diagnosed with a second primary malignancy between 1992 and 2008, according to results of a SEER analysis.